Silver Sponsors


​Beigene gmbh

BeiGene is a global, commercial-stage, research-based biotechnology company focused on molecularly-targeted and immuno-oncology cancer therapeutics. With a team of over 1,100 employees in China, the United States, and Australia, BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer. BeiGene is also working to create combination solutions aimed to have both a meaningful and lasting impact on cancer patients. BeiGene markets ABRAXANE® (nanoparticle albumin–bound paclitaxel), REVLIMID® (lenalidomide), and VIDAZA® (azaciditine) in China under a license from Celgene Corporation.

www.beigene.com


​Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

www.bms.com

​Emerald Health Sciences 

Emerald Health Sciences (EHS) is a diversified cannabis company positioned to take advantage of the significant projected growth in different segments of the cannabis industry. The target segments are Pharmaceuticals, Therapeutic (Medical and Recreational), and Bioceuticals. Each investment leverages the scientific rigor, federal regulatory compliance, and life-science expertise of Emerald Health Sciences’ leadership.

​www.emerald.life

​
​TORREYA PARTNERS, LLP

Torreya Partners, LLP is a leading boutique advisory firm that provides strategic advice and assistance with Mergers & Acquisitions, Partnering and Financings to life science companies worldwide. Torreya Partners provides the long-term thinking and objective advice required for life science companies to create lasting value. We take great pride in handling complex financial and strategic matters for some of the most sophisticated private and public life science companies in the world. Our reputation has been built on quality advice, excellence in deal execution and good outcomes for our clients. We bring the caliber of people and quality of relationships found in some of the largest investment banks along with the attentive, detailed service you expect from a boutique advisory firm. Torreya Partners has offices located in New York, Philadelphia and San Francisco

​www.torreya.com

bronze sponsor

msd

​Merck & Co., Inc., Kenilworth, New Jersey, USA is known as MSD outside of the United States and Canada.
 
 
A Legacy of Innovation
MSD has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide.  From MSD’s development of the first measles and mumps vaccines to treatments for cancer and diabetes, we are an industry leader in bringing forth innovative new medicines.  In 2017 MSD had sales of more than $40 billion and we operate in more than 140 countries.

Partnering With MSD
We recognize that building partnerships is one of our most important jobs.  In 2017, over 60% of our human health sales were attributable to alliance partnerships and patents.  In addition to our headquarters team based in Kenilworth, N.J., we have BD&L professionals in key biomedical innovation epicenters including—Boston, San Francisco, London and Shanghai.
 
We’re pursuing some of the most innovative areas in biomedical research emerging today without regard to therapeutic area/modality.  With 100 business development transactions since 2016, our team has experience working on collaborations from discovery to clinical-stage programs.  We believe that by working together we can play a major role in transforming global health care.  Together we can invent for life.

msd.com/licensing

Contributing Sponsors

​
​Arix Bioscience PLC

Arix Bioscience plc is a global healthcare and life science company supporting medical innovation. Headquartered in London and with an office in New York, Arix Bioscience sources, finances and builds world class healthcare and life science businesses addressing medical innovation at all stages of development. Operations are supported by privileged access to breakthrough academic science and strategic relationships with leading research accelerators and global pharmaceutical companies. Arix Bioscience plc is listed on the Main Market of the London Stock Exchange.
​
www.arixbioscience.com

​

​​NOVO HOLDINGS A/S​

Novo Seeds is the early stage investment arm of Novo Holdings. Novo Holdings is the holding company in the Novo Group, responsible for the management of the assets of the Novo Nordisk Foundation, which are currently valued at more than USD 30 billion. Novo A/S is a private limited liability company fully owned by the Novo Nordisk Foundation. Besides being the major shareholder in Novo Nordisk A/S and Novozymes A/S, Novo A/S provides seed and venture capital to development stage companies and takes significant ownership positions in well-established companies, within life science and biotechnology, as well as manages a broad portfolio of financial assets.

www.novo.dk


​BioMedPartners AG

BioMedPartners AG is a Basel-based Life Science Venture Capital Firm that invests in innovative private early- to mid-stage human Life Science companies in Switzerland and surrounding EU countries. It has recently raised a new fund, BioMedInvest-III LP, at CHF 100 million, and has now a total of CHF 350 million under management.

www.biomedvc.com

​

​​TVM CAPITAL LIFE SCIENCE

TVM Capital Life Science is a group of independent investment advisories and fund managers for Venture Capital funds, investing into innovative biotech, pharmaceutical, and medtech companies with teams based in Munich and Montreal. Since 1984, TVM Capital Life Science has invested in more than 140 life science companies in Europe, Canada and the United States, currently managing in excess of US$1.1 billion from more than 50 investors.

www.tvm-lifescience.com

Euronext

Euronext is the leading pan-European exchange in the Eurozone, covering Belgium, France, Ireland, The Netherlands, Portugal and the UK. With 1,300 listed issuers worth €3.7 trillion in market capitalisation as of end March 2018, Euronext is an unmatched blue chip franchise that has 25 issuers in the Morningstar® Eurozone 50 Index℠ and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, Euronext also operates Euronext GrowthTM and Euronext AccessTM, simplifying access to listing for SMEs.

www.euronext.com

LANYARD SPONSOR

​M Ventures

M Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From our headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. M Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and coinvestors to translate innovation towards commercial success. M Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
​
www.m-ventures.com
​

Rising Stars Sponsor

ECONOMIC AND TRADE DEPARTMENT, EMBASSY OF ISRAEL

The Economic & Trade Department of the Embassy of Israel promotes, enhances and facilitates trade, investment and industrial R&D between Switzerland and Israel.
We offer Israeli companies a wide range of business development services to connect with partners in Switzerland. Our activities include business seminars, delegations, investment events, market briefings, and business meetings scheduling.
The Economic & Trade Department offers Swiss companies access to Israeli technology and Innovation through events, exhibitions, delegations and investment events. We also facilitate scouting for cutting-edge technologies and access to business opportunities from Israel.

http://www.itrade.gov.il/switzerland/